John G. Lemkey, Officer, Chief Operating Officer, Chief Executive Officer, Chief Financial Officer at Odonate Therapeutics, Inc. (ODT), bought 60,000 shares at $13.17 ($756K) on 2018-12-20, disclosed to the SEC on 2018-12-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.17 | 10,000 | $132K | 17.4% |
| 2 | $12.27 | 10,000 | $123K | 16.2% |
| 3 | $12.44 | 3,500 | $44K | 5.8% |
| 4 | $13.78 | 6,500 | $90K | 11.9% |
| 5 | $12.09 | 10,000 | $121K | 16.0% |
| 6 | $12.34 | 10,000 |
| $123K |
| 16.3% |
| 7 | $12.40 | 10,000 | $124K | 16.4% |
| Total | $12.60 avg | 60,000 | $756K | 100% |
| Filing → |
| ODT | BUY | 2019-03-11 | $4.7M | — | Filing → |
| ODT | BUY | 2018-12-18 | $848K | — | Filing → |
| ODT | BUY | 2018-10-25 | $919K | — | Filing → |